Although technology has long affected the labor force, recent advances in artificial intelligence and robotics are heightening concerns about automation replacing a growing number of occupations, including highly skilled or “knowledge-based” jobs.
Just a few examples: self-driving technology may eliminate the need for taxi, Uber and truck drivers, algorithms are playing a growing role in journalism, robots are informing consumers as mall greeters, and medicine is adapting robotic surgery and artificial intelligence to detect cancer and heart conditions.
More than 45 million couples worldwide grapple with infertility, but current standard methods for diagnosing male infertility can be expensive, labor-intensive, and require testing in a clinical setting.
Cultural and social stigma, and lack of access in resource-limited countries, may prevent men from seeking an evaluation. Investigators at Harvard-affiliated Brigham and Women’s Hospital (BWH) and Massachusetts General Hospital (MGH) set out to develop a home-based diagnostic test that could be used to measure semen quality with a smartphone-based device. New findings by the team indicating that the analyzer can identify abnormal semen samples based on sperm concentration and motility criteria with approximately 98 percent accuracy are published online in today’s Science Translational Medicine.
“We wanted to come up with a solution to make male infertility testing as simple and affordable as home pregnancy tests,” said Hadi Shafiee, a principal investigator in the Division of Engineering in Medicine and Renal Division of Medicine at BWH. “Men have to provide semen samples in these rooms at a hospital, a situation in which they often experience stress, embarrassment, pessimism, and disappointment. Current clinical tests are lab-based, time-consuming, and subjective. This test is low-cost, quantitative, highly accurate, and can analyze a video of an undiluted, unwashed semen sample in less than five seconds.”
Two Provo doctors are using Microsoft’s HoloLens with advanced medical imaging to create holograms of MRIs and X-rays, and they’re certain this will change the way surgeons operate.
Every minute in the United States, 30 people require a blood transfusion. That equates to a lot of blood, and the problem is that not enough people donate. This bottleneck has long been an issue for medicine, and so many have been trying to find a way to artificially create large volumes to meet this demand.
A team of researchers from the University of Bristol and NHS Blood and Transplant may have finally cracked it. They’ve made a major breakthrough in the process of mass producing red blood cells, in what could technically be an unlimited supply of the stuff. While they now have a biological way of achieving this, they now need the manufacturing technology on a large enough scale in order to mass produce it.
Scientists have been able to create artificial blood before, but these earlier methods have been incredibly inefficient. They worked by taking stem cells, and then directly inducing them to form red blood cells. By doing this, they could create maybe 50,000 cells in one go, far short of the trillions typically needed for a blood transfusion.
UNSW researchers have identified a critical step in the molecular process that allows cells to repair damaged DNA – and it could mean big things for the future of anti-ageing drugs, childhood cancer survivors and even astronauts.
Roboticists frequently turn to nature for inspiration for their inventions, reverse engineering the traits that evolution has developed over millennia. Others are taking a shortcut by simply integrating modern technology with living animals.
The idea may seem crazy, but animals and machines are not so different. Just as a network of wires carry electrical signals between a robot’s sensors, processing units and motors, the flow of action potentials around our nervous system connects our sensory organs, brain and muscles.
But while there are similarities, the natural world has come up with some intricate solutions to problems that engineers are nowhere near replicating in silicon. That has prompted some scientists to try and piggyback on evolution’s innovations by building part-animal, part-machine cyborgs. Here’s a rundown of some of the most eye-catching examples.
UNSW researchers have identified a critical step in the molecular process that allows cells to repair damaged DNA – and it could mean big things for the future of anti-ageing drugs, childhood cancer survivors and even astronauts. It could lead to a revolutionary drug that actually reverses ageing, improves DNA repair and could even help NASA get its astronauts to Mars.
Their experiments in mice suggest a treatment is possible for DNA damage from ageing and radiation. It is so promising it has attracted the attention of NASA, which believes the treatment can help its Mars mission.
While our cells have an innate capability to repair DNA damage − which happens every time we go out into the sun, for example – their ability to do this declines as we age.
Some parts of the body – including the tissues of the brain and testes – have long been considered to be completely hidden from our immune system.
Last year scientists made the amazing discovery that a set of previously unseen channels connected the brain to our immune system; now, it appears we might also need to rethink the immune system’s relationship with the testes, potentially explaining why some men are infertile and how some cancer vaccines fail to provide immunity.
Researchers from University of Virginia School of Medicine discovered a ‘very small door’ which allows the testes to expose some of its antigens to the immune system without letting it inside.
